image
SELLAS Life Sciences Group, Inc. SLS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.63
1.88 %
$ 163 M
Market Cap
-4.41
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
--12.38%
Net Income Estimate
145.43%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets SELLAS Life Sciences Group, Inc.
image
SLS has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart SLS

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020152015202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart SLS

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)20152015202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart SLS

image
$50.0b$50.0b$0.0$0.0($50.0b)($50.0b)($100.0b)($100.0b)($150.0b)($150.0b)($200.0b)($200.0b)($250.0b)($250.0b)20152015202120212022202220232023202420242025202520262026202720272028202820292029